IoT News, Publications, Magazine & Newsletter | IoT Now

Researchers, clinical trial participants, physicians, and others can now access cloud-based Independent E-Signatures™ via the Exostar Life Sciences Identity Hub.

Exostar and SIGNiX, a provider of Independent E-Signatures™, have announced a relationship that brings SIGNiX’s digital signature solution to Exostar’s life science and healthcare communities.  With SIGNiX becoming Exostar’s latest Application Partner, organisations and individuals connected to Exostar’s Life Sciences Identity Hub can leverage secure, single sign-on access to SIGNiX to quickly and easily sign business-critical and sensitive documents and forms online.

“Now, more than ever, parties in the life sciences and healthcare industries must be able to collaborate with one another securely, efficiently, effectively, and compliantly.  At the same time, performance cannot be compromised by scale,” said Jay Jumper, SIGNiX’s CEO.  “Exostar’s Life Sciences Identity Hub addresses these stringent requirements.  By becoming a partner and connecting our application to the Identity Hub, we are adding value to Exostar’s compelling service offering.”

SIGNiX’s Independent E-Signatures comply with global life sciences and healthcare industry standards and regulations, including the FDA’s 21 CFR Part 11, HIPAA, and the ESIGN Act. They have also been approved by the SAFE-BioPharma Association, the non-profit organization that manages digital identity and signature standards for the pharmaceutical, biotech, and healthcare industries.

Researchers, investigators, patients, providers, and clinical trial participants benefit from signature process enforcement, faster document turnaround, reduced operating costs, and the flexibility to sign, send, and track documents from any device with an Internet connection.  Because SIGNiX’s Independent E-Signatures rely on a fundamentally different technical approach, based entirely on secure digital signature, Exostar community members will realise additional advantages, including:

• Ownership and Control – Users determine where documents reside, including on their own servers, rather than the vendor’s external server.  Legal evidence is permanently embedded into the signed document so that signatures can be verified offline, anytime.
• Perpetual Validity – Because the legal evidence behind each signature is permanently embedded into the signed document and signatures adhere to international, published standards, they are valid virtually forever, as long as a digital copy of the signed document exists.
• Transparency – Users get immediate and complete access to the evidence of the signature’s validity through a comprehensive audit trail.

Exostar’s cloud-based Life Sciences Identity Hub supports a community of nearly 1,000 organisations and 20,000 individuals worldwide in their life science and healthcare endeavors.  It serves not only as a platform that enables secure, internal and external collaboration, but also as a single sign-on entry point to a wealth of connected applications and solution provider portals that advance business objectives.  Owners of connected assets define permission and user authentication strategies and rules, which are enforced by Exostar’s Secure Access Manager.  Coupled with extensive platform security and audit capabilities, application providers receive a secure connection experience, while sponsor organisations are assured their sensitive information and intellectual property are protected from compromise.

“Life science and healthcare organisations are demanding federated access to leading edge solutions, such as SIGNiX’s Independent E-Signatures, that enhance their productivity without sacrificing security or compliance,” said Daniel Pfeifle, Exostar’s vice president of Sales and Marketing.  “Our Partner Program is gaining momentum as Application Partners like SIGNiX recognize the vitally important role they can play in meeting this pressing need.”